Healthy Adult Volunteers Clinical Trial
Official title:
Metabolism of Isotonic Versus Hypotonic Maintenance Solutions in Fasting Healthy Adults, a Single-Blind Randomized Crossover Trial
The prescription of intravenous maintenance solutions - although widespread - lacks important data on the optimal sodium and potassium content, which has given rise to an important debate in the scientific literature. Our study compares two different infusion fluids in 12 healthy adult volunteers without renal failure in a single-blind randomized crossover design over two 48 hour periods during which subjects are not allowed to eat or drink. Fluid 1 is a premixed solution containing 54 mmol/L of sodium and 26 mmol/L of potassium; fluid 2 is sodium chloride 0.9% in glucose 5% with 40 mmol/L of potassium. Both solutions are administered at 25 mL/kg of ideal body weight, as recommended by current guidelines (NICE 174) and both solutions are widely used in daily clinical practice. The primary hypothesis is that isotonic maintenance solutions lead to more fluid retention than hypotonic fluids. Metabolism of both solutions is assessed by sequential analysis of urine and serum, clinical parameters and bioelectrical impedance analysis.
n/a
Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT06034899 -
A Study to Evaluate the Effect of Food on the Drug Levels of BMS-986196 in Healthy Adult Participants
|
Phase 1 | |
Completed |
NCT05162274 -
Clinical Trial to Assess Bioequivalence of Lazertinib Between Two Formulations in Healthy Volunteers.
|
Phase 1 | |
Completed |
NCT03748758 -
Evaluation of Safety of Repeated Doses of OP0201 Metered Dose Inhaler Compared to Placebo in Healthy Adult Volunteers
|
Phase 1 | |
Recruiting |
NCT06008652 -
A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DR-0201 in Healthy Adult Volunteers
|
Phase 1 | |
Terminated |
NCT02079480 -
Study to Evaluate the Safety, Tolerability, PK, and PD of BMS-986090 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01651325 -
Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Dextromethorphan in Healthy Adult Subjects
|
Phase 1 | |
Completed |
NCT01657838 -
Drug Interaction Study of the Effect of Ketoconazole at Steady State on the Pharmacokinetics of a Single Dose of Isavuconazole in Healthy Adult Subjects
|
Phase 1 | |
Completed |
NCT01354379 -
Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008 Administered by Sprayer
|
Phase 1 | |
Completed |
NCT01129466 -
Effects of 2 Different Broccoli Sprout Containing Supplements on Nasal Cells in Healthy Volunteers
|
N/A | |
Completed |
NCT04856969 -
Clinical Trial to Evaluate Pharmacokinetic Interaction of ATB-1011 and ATB-1012 in Healthy Adult Volunteers
|
Phase 1 | |
Completed |
NCT01333462 -
Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008
|
Phase 1 | |
Completed |
NCT02942771 -
A MAD Study of TT301/MW189 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05017987 -
Clinical Trial to Compare Pharmacokinetics After Administration of ATB-101 or Co-administration of ATB-1011 and ATB-1012
|
Phase 1 | |
Not yet recruiting |
NCT05757596 -
Study of VSA001 Injection in Chinese Healthy Adult Volunteers
|
Phase 1 | |
Completed |
NCT05074368 -
Efficacy and Safety of Heterologous and Homologous COVID-19 Vaccination
|
N/A | |
Completed |
NCT01672242 -
Assessment of End Expiratory Lung Volumes in Healthy Subjects Using High Flow Oxygen (Vapotherm®)
|
N/A | |
Completed |
NCT03878693 -
4-methylpyrazole and Acetaminophen Metabolism
|
Early Phase 1 | |
Completed |
NCT04204772 -
A Pilot Feasibility Study of Activated Charcoal in Healthy Volunteers
|
Early Phase 1 | |
Completed |
NCT05154461 -
Intestinal Ketone Bodies Interfere With the Glycemic Control
|
N/A | |
Active, not recruiting |
NCT02058472 -
Pharmacokinetic/Pharmacodynamic & Safety Study of G3041 and SEVIKAR® Tablet in Healthy Adult Volunteers
|
Phase 1 |